Exchange Traded Concepts’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177K Buy
3,386
+314
+10% +$18.8K ﹤0.01% 1263
2025
Q4
$181K Sell
3,072
-558
-15% -$33.9K ﹤0.01% 1268
2025
Q3
$202K Buy
3,630
+192
+6% +$10.3K ﹤0.01% 1193
2025
Q2
$177K Buy
3,438
+635
+23% +$31.9K ﹤0.01% 1191
2025
Q1
$164K Buy
2,803
+490
+21% +$33.2K ﹤0.01% 1031
2024
Q4
$167K Sell
2,313
-5
-0.2% -$367 ﹤0.01% 1032
2024
Q3
$185K Buy
+2,318
New +$174K ﹤0.01% 989
2023
Q3
Sell
-335
Closed -$27.3K 1496
2023
Q2
$27.3K Buy
+335
New +$26.9K ﹤0.01% 1139
2022
Q1
Sell
-816
Closed -$106K 1362
2021
Q4
$106K Buy
816
+56
+7% +$6.87K ﹤0.01% 843
2021
Q3
$92K Sell
760
-4,612
-86% -$561K ﹤0.01% 789
2021
Q2
$605K Buy
5,372
+176
+3% +$18.5K 0.02% 454
2021
Q1
$496K Sell
5,196
-484
-9% -$44.2K 0.02% 490
2020
Q4
$451K Buy
5,680
+644
+13% +$46.6K 0.02% 395
2020
Q3
$312K Buy
5,036
+532
+12% +$34.6K 0.02% 460
2020
Q2
$297K Buy
+4,504
New +$270K 0.05% 384

Other funds holding TECH

Exchange Traded Concepts's TECH Position: Q1 2026 in Review

Exchange Traded Concepts increased its Bio-Techne (TECH) stake by 10% in Q1 2026, buying an estimated $18.8K and bringing the position to 3,386 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.

Exchange Traded Concepts first reported a position in TECH in Q2 2020 and has held it in 15 quarters since. The position peaked at $605K in Q2 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Exchange Traded Concepts held 3,386 shares of Bio-Techne worth $177K as of Q1 2026.
  • Exchange Traded Concepts bought 314 Bio-Techne shares in Q1 2026, an estimated $18.8K.
  • Bio-Techne made up ﹤0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #1263 holding.
  • Exchange Traded Concepts first reported a position in Bio-Techne in Q2 2020 and has held it in 15 quarters since.
  • Exchange Traded Concepts's Bio-Techne position peaked at $605K in Q2 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.